Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic β-cell mass with positron emission tomography (PET)

Publication | Closed Access

DOI

Citations

References

2004

Year

Björn Wängler, Stephan Schneider, Oliver Thews, Esther Schirrmacher, Slobodan Comagic, Peter J. Feilen, Christina Schwanstecher, Mathias Schwanstecher, Chyng‐Yann Shiue, Abass Alavi,

Nuclear Medicine and Biology

Positron Emission TomographyPromising RadioligandPancreatic β-Cell MassEngineeringBiochemistryMedicineMass SpectrometryRadioanalytical ChemistryRadiopharmaceutical TherapyAnalytical ChemistryPharmacologyMolecular ImagingNuclear Medicine